Table 1 Clinical characteristics of the included 147 non-M3 AML patients and the their survival status
From: Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia
Characteristics | Deceased (n = 96) | Living (n = 51) | P value |
|---|---|---|---|
Age | 58.2 ± 16.2 | 49.2 ± 14.4 | 0.001 |
Gender | |||
Male | 52 | 28 | 0.932* |
Female | 44 | 23 | |
Risk category a | |||
Favorable | 7 | 12 | 0.022 * |
Intermediate | 64 | 30 | |
Poor | 23 | 9 | |
FAB morphologyb | |||
M0 Undifferentiated | 8 | 5 | 0.767* |
M1 | 23 | 13 | |
M2 | 22 | 14 | |
M4 | 27 | 12 | |
M5 | 11 | 6 | |
M6 | 2 | 0 | |
M7 | 3 | 0 | |